TGM2高表达对GES1细胞生长增殖的影响(3)
Katoh H， Ishikawa S. Genomic pathobiology of gastric carcinoma[J].Pathol Int. 2017，67(2)：63-71.
Chen W， Zheng R， Baade PD， et al. Cancer statistics in China， 2015[J]. CA Cancer J Clin. 2016，66(2)：115-132.
張志伟， 汤国辉， 赵强， 等. AKT-p27Kip1-Cyclin E在胃癌组织中的表达及意义[J].世界华人消化杂志，2011，19(21)：2233-2240.
张志伟. 胃粘膜上皮癌变相关蛋白质分子的筛选与鉴定[D]. 2015， 南华大学博士学位论文.
Pietsch M， Wodtke R， Pietzsch J， et al. Tissue transglutaminase：an emerging target for therapy and imaging[J]. Bioorg Med Chem Lett. 2013， 23(24)：6528-6543.
Li B， Cerione RA， Antonyak M. Tissue transglutaminase and its role in human cancer progression[J]. Adv Enzymol Relat Areas Mol Biol. 2011， 78：247-293.
Budillon A， Carbone C， Di Gennaro E. Tissue transglutaminase：a new target to reverse cancer drug resistance[J]. Amino Acids. 2013， 44(1)：63-72.
Nadalutti C， Viiri KM， Kaukinen K， et al. Extracellular transglutaminase 2 has a role in cell adhesion， whereas intracellular transglutaminase 2 is involved in regulation of endothelial cell proliferation and apoptosis[J]. Cell Prolif. 2011， 44(1)：49-58.
Jiang D， Ying W， Lu Y， et al. Identification of metastasis-associated proteins by proteomic analysis and functional exploration of interleukin-18 in metastasis[J]. Proteomics. 2003， 3(5)：724-737.
Antonyak MA， Miller AM， Jansen JM， et al. Augmentation of tissue transglutaminase expression and activation by epi-dermal growth factor inhibit doxorubicin-induced apoptosis in human breast cancer cells[J]. J Biol Chem. 2004， 79(40)：41461-41467.
Fu J， Yang QY， Sai K， et al. TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells[J]. Neuro Oncol. 2013，15(10)：1353-65.
Obinata A， Osakabe K， Yamaguchi M， et al. Tgm2/Gh， Gbx1 and TGF-beta are involved in retinoic acid-induced transdifferentiation from epidermis to mucosal epithelium[J]. Int J Dev Biol. 2011，55(10-12)：933-43., 百拇医药(吴霞 艾小红 彭顺清)
Chen W， Zheng R， Baade PD， et al. Cancer statistics in China， 2015[J]. CA Cancer J Clin. 2016，66(2)：115-132.
張志伟， 汤国辉， 赵强， 等. AKT-p27Kip1-Cyclin E在胃癌组织中的表达及意义[J].世界华人消化杂志，2011，19(21)：2233-2240.
张志伟. 胃粘膜上皮癌变相关蛋白质分子的筛选与鉴定[D]. 2015， 南华大学博士学位论文.
Pietsch M， Wodtke R， Pietzsch J， et al. Tissue transglutaminase：an emerging target for therapy and imaging[J]. Bioorg Med Chem Lett. 2013， 23(24)：6528-6543.
Li B， Cerione RA， Antonyak M. Tissue transglutaminase and its role in human cancer progression[J]. Adv Enzymol Relat Areas Mol Biol. 2011， 78：247-293.
Budillon A， Carbone C， Di Gennaro E. Tissue transglutaminase：a new target to reverse cancer drug resistance[J]. Amino Acids. 2013， 44(1)：63-72.
Nadalutti C， Viiri KM， Kaukinen K， et al. Extracellular transglutaminase 2 has a role in cell adhesion， whereas intracellular transglutaminase 2 is involved in regulation of endothelial cell proliferation and apoptosis[J]. Cell Prolif. 2011， 44(1)：49-58.
Jiang D， Ying W， Lu Y， et al. Identification of metastasis-associated proteins by proteomic analysis and functional exploration of interleukin-18 in metastasis[J]. Proteomics. 2003， 3(5)：724-737.
Antonyak MA， Miller AM， Jansen JM， et al. Augmentation of tissue transglutaminase expression and activation by epi-dermal growth factor inhibit doxorubicin-induced apoptosis in human breast cancer cells[J]. J Biol Chem. 2004， 79(40)：41461-41467.
Fu J， Yang QY， Sai K， et al. TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells[J]. Neuro Oncol. 2013，15(10)：1353-65.
Obinata A， Osakabe K， Yamaguchi M， et al. Tgm2/Gh， Gbx1 and TGF-beta are involved in retinoic acid-induced transdifferentiation from epidermis to mucosal epithelium[J]. Int J Dev Biol. 2011，55(10-12)：933-43., 百拇医药(吴霞 艾小红 彭顺清)